Regulation  101 CMR 801.00: Drug manufacturer negotiations and accountability

Date:	03/06/2020
Organization:	Executive Office of Health and Human Services
Regulatory Authority:	MGL c. 118E, § 12A
Official Version:	Purchase the official print version

101 CMR 801.00 governs the process for direct negotiations between the Executive Office of Health and Human Services (EOHHS) and manufacturers for supplemental rebate agreements (SRAs), the public process for determining a drug's target value, and referrals of manufacturers to the Health Policy Commission (HPC).

• See also Related and supporting documents for 101 CMR 801 (EOHHS)

Download a PDF copy of the regulation below.